Clinical evaluation of ultrasmall superparamagnetic iron oxide particles for liver imaging.
Saini
S
S
Department of Radiology, Massachusetts General Hospital 02114, USA.
Edelman
R R
RR
Li
W
W
Petersein
J
J
Hahn
P F
PF
D006528:Carcinoma, Hepatocellular / Q000175:diagnosis*; D003287:Contrast Media / Q000493:pharmacokinetics; D003560:Cysts / Q000175:diagnosis*; D003911:Dextrans; D005260:Female; D005290:Ferric Compounds / Q000493:pharmacokinetics; D052203:Ferrosoferric Oxide; D006391:Hemangioma / Q000175:diagnosis*; D006801:Humans; D007089:Image Enhancement; D007501:Iron / Q000493:pharmacokinetics; D008099:Liver / Q000473:pathology*; D008107:Liver Diseases / Q000175:diagnosis*; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000556:secondary; D008279:Magnetic Resonance Imaging; D058185:Magnetite Nanoparticles; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D010087:Oxides / Q000493:pharmacokinetics
D003287:Contrast Media; D003911:Dextrans; D005290:Ferric Compounds; D058185:Magnetite Nanoparticles; D010087:Oxides; C097921:ferumoxtran-10; C000499:ferric oxide; D007501:Iron; D052203:Ferrosoferric Oxide